lobbying_activities: 2772609

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2772609	ff9af9af-b94d-4724-b3bd-dd9224963597	Q1	PUBLIC CITIZEN	32362	PUBLIC CITIZEN	2022	first_quarter	PHA	HR 5376-Build Back Better Act-drug pricing measures, pandemic preparedness and vaccine manufacturing, HR 6000 (CURES 2.0) antimicrobial development provisions, HR 4502-FY22 Consolidated Appropriations Act-Covid-19 vaccine manufacturing, Affordable Insulin NOW Act, Discounted drugs for clinical trials act, Pharmaceutical Research and transparency, S 2891-Restoring the America Invents Act, HR 4521-America COMPETES act, Plain prescription Prices act, S 3799-PREVENT Pandemics Act, COVID 19 vaccine manufacturing and delivery.	HOUSE OF REPRESENTATIVES,SENATE		70000	0	0	2022-04-13T09:38:09-04:00